lipoxin a4 has been researched along with Cystic Fibrosis of Pancreas in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, PJ; Harvey, BJ; McNally, P; Urbach, V | 1 |
| Al-Alawi, M; Buchanan, P; Costello, RW; Harvey, BJ; Higgins, G; McNally, P; Perriere, M; Urbach, V; Verriere, V | 1 |
| Buchanan, PJ; Clarke, DT; Harvey, BJ; Linnane, B; McDermott, M; McNally, P; Millar, RG; Ringholz, FC; Urbach, V | 1 |
| Buchanan, P; Higgins, G; McNally, P; Ringholz, F; Urbach, V | 1 |
| Fustero Torre, C; Harvey, BJ; Higgins, G; McNally, P; Tyrrell, J; Urbach, V | 1 |
| Bahl, CD; Bomberger, JM; Eddens, T; Flitter, BA; Hammock, BD; Hampton, TH; Hvorecny, KL; Kolls, JK; Kwak, DH; Lee, JS; Levy, BD; Liu, X; Madden, DR; Morisseau, C; Ono, E; Yang, J | 1 |
| Chiron, R; Grumbach, YY; Quynh, NV; Urbach, V; Verriere, V | 1 |
| Al-Alawi, M; Chiron, R; Costello, RW; Harvey, BJ; Higgins, G; McNally, P; Urbach, V; Verrière, V | 1 |
| Griese, M; Paul, K; Ratjen, F; Rietschel, E; Starosta, V | 1 |
1 review(s) available for lipoxin a4 and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Physiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential.
Topics: Adenosine Triphosphate; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelium; Humans; Inflammation; Lipoxins; Lung; Respiratory Mucosa; Signal Transduction | 2015 |
1 trial(s) available for lipoxin a4 and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Infusions, Intravenous; Interleukin-8; Lipoxins; Male; Middle Aged; Prospective Studies; Sputum; Treatment Outcome; Vital Capacity; Young Adult | 2008 |
7 other study(ies) available for lipoxin a4 and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Lipoxin A₄-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Cell Proliferation; Cystic Fibrosis; Epithelial Cells; Flavonoids; Glyburide; Humans; Hypoglycemic Agents; KATP Channels; Lipoxins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Protein Kinase Inhibitors; Receptors, Formyl Peptide; Receptors, Lipoxin; Respiratory Mucosa | 2013 |
Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Autocrine Communication; Calcium Signaling; Cell Line; Cell Movement; Cell Proliferation; Connexins; Cyclic AMP; Cystic Fibrosis; Epithelial Cells; Humans; Lipoxins; Lung; Nerve Tissue Proteins; Primary Cell Culture; Purinergic P2 Receptor Antagonists; Receptors, Formyl Peptide; Receptors, Lipoxin; Receptors, Purinergic P2; Regeneration; Respiratory Mucosa; Signal Transduction; Time Factors | 2014 |
Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis.
Topics: Anti-Bacterial Agents; Arachidonate 15-Lipoxygenase; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Inflammation; Leukotriene A4; Leukotriene B4; Lipoxins; Longitudinal Studies; Lung; Lung Diseases; Macrophages, Alveolar; Male; Neutrophils | 2014 |
Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic fibrosis bronchial epithelial cells by Pseudomonas aeruginosa.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cystic Fibrosis; Drug Evaluation, Preclinical; Epithelial Cells; Gene Expression; Humans; Lipoxins; Pseudomonas aeruginosa; Pseudomonas Infections; Receptors, Formyl Peptide; Receptors, Lipoxin; Respiratory Mucosa; Tight Junctions; Zonula Occludens-1 Protein | 2016 |
Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators.
Topics: 8,11,14-Eicosatrienoic Acid; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Cell Line; Crystallography, X-Ray; Cystic Fibrosis; Humans; Inflammation; Lipoxins; Lung Diseases; Neutrophil Activation; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Virulence Factors | 2017 |
Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium; Child, Preschool; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Lipoxins; Primary Cell Culture; Receptors, Formyl Peptide; Receptors, Lipoxin; Respiratory Mucosa | 2012 |
Anti-inflammatory cytokines in cystic fibrosis lung disease.
Topics: Adolescent; Adult; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Cystic Fibrosis; Cytokines; Female; Humans; Inflammation Mediators; Lipoxins; Lung Diseases; Male; Uteroglobin | 2006 |